课题基金 / 基金详情

Total Synthesis of Antitumor Agent Eupenifeldin

Total Synthesis of Antitumor Agent Eupenifeldin
抗肿瘤药Eupenifeldin的全合成
批准号:
6825359
负责人:
DANNY NG
金额:
$4.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-08-01 至 2006-07-31

项目摘要

项目成果

DANNY NG的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):自然界是各类抗肿瘤化合物的重要来源。最近,从短毛真球藻ATCC 74184的发酵液中分离到一种新的细胞毒性双环蛋白Eupenifeldin。初步实验表明,优苯非菌素对人结肠癌细胞株HCT-116和人结肠癌细胞株HCT-VM4有较强的体外毒性,其IC50值分别为5 ng/ml和2 ng/ml。下面的建议描述了标题化合物的高度收敛和对映选择性的全合成。关键步骤包括同时将两个特罗普隆单元引入到十一元核心,以及在一步中两个二氢吡喃环的立体选择性形成。如果成功,建议的路线将为进一步的生物学评价提供大量的天然产物,以及为结构-活性关系研究制备其他非天然类似物的可能性。
英文摘要
DESCRIPTION (provided by applicant): Nature is an important souce of various types of antitumor compounds. Recently a novel cytotoxic bistropolone Eupenifeldin was isolated from a culture broth produced by Eupenicillium brefeldianum ATCC 74184. Preliminary testing shows that Eupenifeldin is highly toxic in vitro against HCT-116 and HCT-VM4(human colon carcinoma) cell lines, with IC50 values of 5 ng/ml and 2 ng/ml, respectively. The following proposal describes a highly convergent and enantioselective total synthesis of the title compound. The key steps include the simultaneous introduction of both tropolone units to the eleven-membered core, as well as the stereoselective formation of both dihydropyran rings in a single step. If successful, the proposed route will provide large amount of the natural prouct for further biological evaluation, as well as the possibility to prepare other non-natural analogues for structure-activity relationship studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Total Synthesis of Antitumor Agent Eupenifeldin
  • 批准号:
    6931912
  • 项目类别:
  • 资助金额:
    $4.4万
  • 财政年份:
    2004
  • 负责人:
    DANNY NG
  • 依托单位:
海外基金